Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

58.75
+0.01010.02%
Volume:995.73K
Turnover:58.73M
Market Cap:10.67B
PE:-40.98
High:59.75
Open:59.47
Low:58.48
Close:58.74
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:1.11
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:23.97
PE(LYR):-41.67

Loading ...

Movement Alert|Tempus AI Intraday Decline 5.34%, Major Shareholder Persistent Selling and Sector Weakness Extend Selling Pressure

Market Focus
·
Jun 05

Movement Alert|Tempus AI Rises 5.28% in Regular Trading, FDA Approval of xT CDx Platform and New AI Launch Continue to Drive Momentum

Market Focus
·
Jun 04

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Reuters
·
Jun 04

Tempus AI launches open-source digital pathology consortium

TIPRANKS
·
Jun 03

Movement Alert|Tempus AI Intraday Decline 5.48%, Major Shareholder Continued Selling Pressure Compounded by Sector-Wide Weakness

Market Focus
·
Jun 03

Movement Alert|Tempus AI Falls 5.04% in Regular Trading, Trading at $50.6

Market Focus
·
Jun 02

Tempus AI assumed with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Movement Alert|Tempus AI Rises 5.32% in Regular Trading, FDA Approves xT CDx Platform for Tumor-Only Genomic Profiling

Market Focus
·
Jun 01

Tempus AI announced the upcoming clinical availability of xH

TIPRANKS
·
Jun 01

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS
·
Jun 01

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Dow Jones
·
Jun 01

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

TIPRANKS
·
Jun 01

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Short Report: Tempus AI short interest at record high

TIPRANKS
·
Jun 01

Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push

Benzinga Earnings
·
May 31

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

TIPRANKS
·
May 31

Tempus AI announces introduction of Tempus Preview

TIPRANKS
·
May 31

Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million

Reuters
·
May 30